Potential opportunity cost of neglecting to annually reassess Medicare Part D standalone prescription drug plan offerings: The price of contentment?

Medicare beneficiaries should reevaluate PDP offerings annually during the open enrollment period; failure to do so may increase avoidable out-of-pocket costs.